Arun Swaminathan
Corporate Officer/Principal chez COYA THERAPEUTICS, INC.
Postes actifs de Arun Swaminathan
Sociétés | Poste | Début | Fin |
---|---|---|---|
COYA THERAPEUTICS, INC. | Corporate Officer/Principal | 27/03/2023 | - |
Historique de carrière de Arun Swaminathan
Anciens postes connus de Arun Swaminathan
Sociétés | Poste | Début | Fin |
---|---|---|---|
COVANCE INC. | Sales & Marketing | - | - |
Lynkogen, Inc. | Directeur Général | - | - |
Fondateur | - | - | |
ALTEOGEN INC. | Corporate Officer/Principal | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23/09/2021 | - |
Formation de Arun Swaminathan
University of Pittsburgh | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Corée du Sud | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
ALTEOGEN INC. | Health Technology |
COYA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Lynkogen, Inc. |
- Bourse
- Insiders
- Arun Swaminathan
- Expérience